VFP
MRK icon

Verus Financial Partners’s Merck MRK Stock Holding History

Verus Financial Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Buy
3,877
+7
+0.2% +$819 0.04% 77
2026
Q1 		$447K Buy
3,870
+1
+0% +$115 0.04% 78
2025
Q4 		$416K Buy
3,869
+623
+19% +$58.5K 0.04% 79
2025
Q3 		$272K Sell
3,246
-223
-6% -$18.4K 0.03% 101
2025
Q2 		$290K Buy
3,469
+101
+3% +$8.03K 0.03% 90
2025
Q1 		$264K Sell
3,368
-74
-2% -$6.91K 0.03% 88
2024
Q4 		$342K Sell
3,442
-71
-2% -$7.32K 0.04% 71
2024
Q3 		$403K Buy
3,513
+26
+0.7% +$3.09K 0.04% 63
2024
Q2 		$432K Hold
3,487
– – 0.05% 57
2024
Q1 		$460K Hold
3,487
– – 0.05% 57
2023
Q4 		$421K Sell
3,487
-19
-0.5% -$1.97K 0.05% 63
2023
Q3 		$365K Sell
3,506
-215
-6% -$23.2K 0.05% 64
2023
Q2 		$400K Buy
3,721
+13
+0.4% +$1.48K 0.05% 60
2023
Q1 		$435K Sell
3,708
-45
-1% -$4.86K 0.06% 61
2022
Q4 		$403K Sell
3,753
-316
-8% -$32.3K 0.06% 60
2022
Q3 		$385K Sell
4,069
-39
-0.9% -$3.48K 0.06% 61
2022
Q2 		$370K Buy
4,108
+2
+0% +$177 0.05% 63
2022
Q1 		$352K Sell
4,106
-1,304
-24% -$103K 0.05% 69
2021
Q4 		$415K Hold
5,410
– – 0.05% 58
2021
Q3 		$417K Buy
5,410
+2
+0% +$152 0.06% 57
2021
Q2 		$412K Sell
5,408
-284
-5% -$21.1K 0.06% 58
2021
Q1 		$413K Buy
5,692
+575
+11% +$42.4K 0.07% 57
2020
Q4 		$399K Sell
5,117
-7,531
-60% -$576K 0.07% 53
2020
Q3 		$1M Buy
12,648
+9,439
+294% +$739K 0.37% 54
2020
Q2 		$237K Sell
3,209
-205
-6% -$15.4K 0.05% 63
2020
Q1 		$251K Buy
3,414
+221
+7% +$17.4K 0.08% 59
2019
Q4 		$277K Buy
3,193
+12
+0.4% +$986 0.08% 59
2019
Q3 		$256K Buy
+3,181
New +$255K 0.08% 56

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Verus Financial Partners's MRK Position: Q2 2026 in Review

Verus Financial Partners increased its Merck (MRK) stake by 0.18% in Q2 2026, buying an estimated $819 and bringing the position to 3,877 shares worth $498K. The position accounts for 0.04% of the portfolio, ranked #77.

Verus Financial Partners first reported a position in MRK in Q3 2019 and has held it in 28 quarters since. The position peaked at $1M in Q3 2020. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Verus Financial Partners held 3,877 shares of Merck worth $498K as of Q2 2026.
  • Verus Financial Partners bought 7 Merck shares in Q2 2026, an estimated $819.
  • Merck made up 0.04% of Verus Financial Partners's portfolio in Q2 2026, its #77 holding.
  • Verus Financial Partners first reported a position in Merck in Q3 2019 and has held it in 28 quarters since.
  • Verus Financial Partners's Merck position peaked at $1M in Q3 2020.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Verus Financial Partners's 13F filing for Q2 2026, filed 21 Jul 2026.